Institutional investors purchased a net $204.5 thousand shares of BGMD during the quarter ended March 2015 and now own 9.92% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 94.6 Thousand shares of BG Medicine Inc
KCG AMERICAS LLC Bought 77.2 Thousand shares of BG Medicine Inc
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 25.6 Thousand shares of BG Medicine Inc